Stem cells and their mediators – next generation therapy for bronchopulmonary dysplasia
Bronchopulmonary dysplasia (BPD) remains a major complication of premature birth. Despite great achievements in perinatal medicine over the past decades, there is no treatment for BPD. Recent insights into the biology of stem/progenitor cells have ignited the hope of regenerating damaged organs. Ani...
Main Authors: | Marius Alexander Möbius, Bernard eThébaud |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-07-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fmed.2015.00050/full |
Similar Items
-
Present and Future of Bronchopulmonary Dysplasia
by: Luca Bonadies, et al.
Published: (2020-05-01) -
Mesenchymal Stromal Cell-Derived Extracellular Vesicles for Neonatal Lung Disease: Tiny Particles, Major Promise, Rigorous Requirements for Clinical Translation
by: Flore Lesage, et al.
Published: (2022-03-01) -
Endothelial progenitor cells derived from embryonic stem cells prevent alveolar simplification in a murine model of bronchopulmonary dysplasia
by: Olena A. Kolesnichenko, et al.
Published: (2023-06-01) -
Mesenchymal stromal/stem cells and bronchopulmonary dysplasia
by: Shuqing Zhang, et al.
Published: (2023-10-01) -
Deficiency of endothelial FGFR1 alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice
by: Yanrong Long, et al.
Published: (2022-11-01)